Graft Vs Host Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA withdrawal · 2020-02-17
EMA Application withdrawn: Luxceptar — Kiadis Pharma Netherlands B.V.
EMA status shows that the Luxceptar application has been withdrawn by the applicant.